We test the safety and biological efficacy of these chimeric GALC enzymes in comparison to their unmodified counterpart in HSPCs and neural stem/progenitor cells (NPCs) isolated from Twitcher (TWI) mice (the most common GLD murine model), which represent the effector and target cells, respectively, in GT approaches. The gene discussed is GALC; the disease is Krabbe disease.